Royalty Pharma Stock Performance
as on November 7, 2026 at 2:15 pm IST
Day's Low
Day's High
$66.61$68.15
1.03%
Downside
1.26%
Upside
52 Week's Low
52 Week's High
$37.31$69.7744.56%
Downside
3.67%
Upside
Royalty Pharma share price movements today
- Previous Close
- $67.57
- Open
- $66.63
- Volume
- 3.0M
- Market Cap
- $38.9B
- Dividend Yield
- 1.37%
- Day's Low - High
- $66.61 - $68.15
- 52 Week Low - High
- $37.31 - $69.77
Royalty Pharma Historical Returns
- 1 Month Return
- + 18.57 %
- 3 Month Return
- + 18.55 %
- 1 Year Return
- + 74.53 %
- 3 Year Return
- + 144.28 %
- 5 Year Return
- + 70.29 %
Royalty Pharma Stock Fundamentals & Key Indicators
Check Royalty Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$38.9B
EPS (TTM)
1.69
Dividend Yield
1.37%
Quarterly Earnings Growth YOY
-0.51%
PE Ratio (TTM)
39.81
Industry PE ratio
9.00
PEG Ratio
-1.83
EBITDA
1.5B
Revenue (TTM)
2.6B
Profit Margin
87.34%
Return On Equity TTM
9.94%
Royalty Pharma vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Royalty Pharma with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $38.9B | 70.29% | 39.81 | 87.34% | 1.37% | |
| Neutral | $96.4B | 7.26% | -35.95 | 28.00% | 0.00% | |
| StrongBuy | $44.1B | NA | 27.92 | 87.82% | 0.00% | |
| StrongBuy | $137.5B | 183.69% | 34.94 | 85.57% | 0.00% | |
| Buy | $96.3B | 47.88% | 19.26 | 85.77% | 0.41% |
Stock Returns calculator for Royalty Pharma Stock including INR - Dollar returns
The Royalty Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Royalty Pharma investment value today
Current value as on today
₹1,84,770
Returns
₹84,770
(+84.77%)
Returns from Royalty Pharma Stock
₹74,533 (+74.53%)
Dollar Impact
₹10,237 (+10.24%)
Analyst Recommendation on Royalty Pharma Stock
Based on 5 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 5 analysts, 100% of analysts recommend a 'BUY' rating for Royalty Pharma. Average target price of $65.38
Royalty Pharma Share Price Target
Get share price movements and forecasts by analysts on Royalty Pharma.
What analysts predicted
-2.94%DOWNSIDE
Target Price
$65.38
Current Price
$67.3
Analyzed by
5 Analysts
High
$78
Target
$65.38
Low
$63
Royalty Pharma target price $65.38, a slight downside of -2.94% compared to current price of $67.3. According to 5 analysts rating.
Indian Investors' Interest in Royalty Pharma Stock
Search interest for Royalty Pharma Stock has decreased by -23% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Royalty Pharma Quarterly Profit & Loss
All numbers in Millions USD
Royalty Pharma Annual Profit & Loss
All numbers in Millions USD
Royalty Pharma Quarterly Cash Flow
All numbers in Millions USD
Royalty Pharma Annual Cash Flow
All numbers in Millions USD
Royalty Pharma News & Key Events
Today's Timeline - 04 November
Wed, 06:13 PM
-Royalty Pharma reports Q3 receipts of $890 million, raising full-year guidance to $3.50-$3.55 billion.
Wed, 06:25 PM
-Royalty Pharma's Q3 earnings of $1.21 per share beat estimates, with revenues of $890 million surpassing expectations.
Thu, 00:55 AM
-JPMorgan raises Royalty Pharma's price target to $74, citing strong growth and positive clinical developments.
Insights on Royalty Pharma
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Royalty Pharma plc Class A Ordinary Shares has shown strong profitability over the last two quarters. The net profit increased significantly from $17.88 million to $145 million, reflecting an average growth of 87.7% per quarter.
- POSITIVE IMPACT
Revenue Rich
Royalty Pharma plc Class A Ordinary Shares has shown consistent revenue growth over the last 7 quarters. Revenue increased from $568.24 million to $689.99 million, resulting in an average growth rate of 3.2% each quarter.
- POSITIVE IMPACT
Price Rise
In the last 1 month, RPRX stock has moved up by 19.7%
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 935.8% return, outperforming this stock by 861.3%
- NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 256.3% return, outperforming this stock by 112.6%
About Royalty Pharma
| Organisation | Royalty Pharma |
| Headquarters | 110 East 59th Street, New York, NY, 10022, US |
| Industry | Medical - Pharmaceuticals |
| CEO | Pablo Legorreta |
Key Management of Royalty Pharma
Name | Title |
|---|---|
Mr. Terrance P. Coyne | Executive VP & CFO |
Mr. Christopher Hite | Chairman of Partnering & Investments |
Dr. Marshall Jonathan Urist M.D., Ph.D. | Head of Research & Investments |
Mr. Arthur Richard McGivern J.D. | Executive VP of Investment & Chief Legal Officer |
Ms. Molly Sawaya | Executive VP & Head of Human Capital |
Mr. Pablo Legorreta | Founder, Chairman of the Board & CEO |
Mr. Greg Butz | Executive Vice President of Partnering & Investments |
Mr. Eric Cornelius Schneider | Senior VP & Chief Technology Officer |
Dr. James Folmar Reddoch Ph.D. | Executive VP of Investments & Chief Scientific Officer |
Mr. George Grofik C.F.A., CPA | Senior VP and Head of Investor Relations & Communications |
FAQs
What is Royalty Pharma share price today?
Royalty Pharma share price today is $67.30 as on at the close of the market. Royalty Pharma share today touched a day high of $68.15 and a low of $66.61.
What is the 52 week high and 52 week low for Royalty Pharma share?
Royalty Pharma share touched a 52 week high of $69.77 on and a 52 week low of $37.31 on . Royalty Pharma stock price today i.e. is closed at $67.30,which is 3.54% down from its 52 week high and 80.38% up from its 52 week low.
What is Royalty Pharma's market capitalisation today?
Royalty Pharma market capitalisation is $0.04T as on .
How to invest in Royalty Pharma Stock (RPRX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Royalty Pharma on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Royalty Pharma Stock (RPRX) from India?
Indian investors can start investing in Royalty Pharma (RPRX) shares with as little as ₹93.91000366210938 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹939.10 in Royalty Pharma stock (as per the Rupee-Dollar exchange rate as on ).
Based on Royalty Pharma share’s latest price of $67.30 as on November 7, 2026 at 8:45 am IST, you will get 0.1486 shares of Royalty Pharma. Learn more about
fractional shares .
What are the returns that Royalty Pharma has given to Indian investors in the last 5 years?
Royalty Pharma stock has given 70.29% share price returns and 27.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?